Stock listing
Canopus Biopharma, Inc.
Selected listing: CBIA · OTC · USD · US
Canopus Biopharma, Inc. (OTC:CBIA), Health Technology. Latest release Dec 19, 2014: Canopus BioPharma Inc. announces positive results from an In-Vitro live…
- Ticker
- OTC:CBIA
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Canopus Biopharma, Inc.
The company focuses on biopharmaceutical innovations and developments. Investors can find relevant information about its operations and market performance on its dedicated public company page.
Latest news from Canopus Biopharma, Inc.
Canopus BioPharma Inc. announces positive results from an In-Vitro live Ebola Virus study
December 19, 2014
Canopus BioPharma Inc. Announces Results from Compassionate Study in Hepatitis C patients in China
July 1, 2014
Canopus BioPharma (CBIA), anti-virals selected for screening against MERS-CoV
May 7, 2014
Canopus BioPharma Inc (CBIA) Announces Sale of Two Patents in Sealed-Bid Auction
April 29, 2014
Research Canopus Biopharma, Inc.
Canopus Biopharma, Inc. company profile
View the public company page for Canopus Biopharma, Inc. on 6ix.
Canopus Biopharma, Inc. news
Read company news and market updates connected to Canopus Biopharma, Inc..
Canopus Biopharma, Inc. investor events
Find investor webinars, events, and replay context for Canopus Biopharma, Inc..